Uterine leiomyosarcoma: Analysis of treatment failures and survival

Gynecologic Oncology

Volumn 62, Issue 1, 1996, Pages 25-32

  Gadducci, Angiolo ^a   Landoni, Fabio ^b   Sartori, Enrico ^c   Zola, Paolo ^d   Maggino, Tiziano ^e   Lissoni, Andrea ^b   Bazzurini, Luca ^c   Arisio, Riccardo ^d   Romagnolo, Cesare ^e   Cristofani, Renza ^f  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; HYSTERECTOMY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS CARCINOMA;

EID: 0030200697     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0185     Document Type: Article

References (56)

1. 1. Harlow, B. L., Weiss, N. S., and Lofton, S. The epidemiology of sarcomas of the uterus, J. Natl. Cancer Inst. 76, 399-402 (1986).
2. 2. Norris, H. J., and Zaloudek, C. J. Mesenchymal tumors of the uterus, in Pathology of the female genital tract (A. Blaustein, Ed.), 2nd ed., Springer Verlag, New York, pp. 352-392 (1982).
3. 3. Echt, G., Jepson, J., Steel, J., Langholz, B., Luxton, G., Hernandex, W., Astrahan, M., and Petrovich, Z. Treatment of uterine sarcomas, Cancer 66, 35-39 (1990).
4. 4. Leibsohn, S., d'Ablaing, G., Mishell, D. R., Jr., and Schlaerth, J. B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas, Am. J. Obstet. Gynecol. 162, 968-976 (1990).
5. 5. Vardi, J. A., and Tovell, H. M. Leiomyosarcoma of the uterus: Clinico-pathologic study, Obstet. Gynecol. 56, 428-434 (1980).
6. 6. Barter, J. F., Smith, E. B., Szpak, C. A., Hinshaw, W., Clarke-Pearson, D. L., and Creasman, W. T. Leiomyosarcoma of the uterus: Clinico-pathologic study of 21 cases, Gynecol. Oncol. 21, 220-227 (1985).
7. 7. Schwartz, L. B., Diamond, M. P., and Schwartz, P. E. Leiomyosarcomas: Clinical presentation, Am. J. Obstet. Gynecol. 168, 180-183 (1993).
8. 8. McLeod, A. J., Zornoza, J., and Shirkhoda, A. Leiomyosarcoma: Computed tomographic findings, Radiology 152, 133-136 (1984).
9. 9. Hata, K., Hata, T., Makihara, K., Aoki, S., Takamiya, O., Kitao, M., Harada, Y., and Nagaoka, S. Sonographic findings of uterine leiomyosarcoma, Gynecol. Obstet. Invest. 30, 242-245 (1990).
10. 10. Salazar, O. M., Bonfiglio, T. A., Patten, S. F., Keller, B. E., Feldsteim, M., Dunne, M. E., and Rudolph, J. Uterine sarcomas: Natural history, treatment, and prognosis, Cancer 42, 1152-1160 (1978).
11. 11. Salazar, O. M., and Dunne, M. E. The role of radiation therapy in the management of uterine sarcomas, Int. J. Radiat. Oncol. Biol. Phys. 6, 899-902 (1980).
12. 12. Berchuck, A., Rubin, S. C., Hoskins, W. J., Saigo, P. E., Pierce, V. K., and Lewis, J. L., Jr. Treatment of uterine leiomyosarcoma, Obstet. Gynecol. 71, 845-850 (1988).
13. 13. Kahanpaa, K. V., Wahlstrom, T., Grohn, P., Heinonen, E., Nieminen, U., and Widholm, O. Sarcomas of the uterus: A clinicopathologic study of 119 patients, Obstet. Gynecol. 67, 417-424 (1986).
14. 14. Tinkler, S. D., and Cowie, V. J. Uterine sarcomas: A review of the Edinburgh experience from 1974 to 1992, Br. J. Radiol. 66, 998-1001 (1993).
15. 15. Moskowic, E., MacSweeney, E., Law, M., and Price, A. Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients, Br. J. Radiol. 66, 1009-1015 (1993).
16. 16. Fleming, W. P., Peters, W. A., Kumar, N. B., and Morley, G. W. Autopsy findings in patients with uterine sarcoma, Gynecol. Oncol. 19, 168-172 (1984).
17. 17. Van Nagell, J. R., Jr., Hanson, M. B., Donaldson, E. S., and Gallion, H. H. Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas: A pilot study, Cancer 57, 1451-1454 (1986).
18. 18. Vongtama, V., Karlan, J. R., Piver, S. M., Tsukada, Y., and Moore, R. H. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri, Am. J. Roentgenol. 126, 139-147 (1976).
19. 19. Wheelock, J. B., Krebs, H. B., Schneider, V., and Goplerud, D. R. Uterine sarcoma: Analysis of prognostic variables in 71 cases, Am. J. Obstet. Gynecol. 151, 1016-1022 (1985).
20. 20. Covens, A. L., Nisker, J. A., Chapman, W. B., and Allen, H. H. Uterine sarcoma: An analysis of 74 cases, Am. J. Obstet. Gynecol. 156, 370-374 (1987).
21. 21. Vaquero, J., Martinez, R., El Barkani, A., Gomez-Angulo, J. C., and Escardon, J. Leiomyosarcoma metastatic to the brain with prolonged survival, J. Neurosurg. Sci. 33, 291-292 (1989).
22. 22. Prussia, P. R., Clarke, H. A., Mansoor, G., and Garriques, S. Uterine leiomyosarcoma with intracerebral metastasis: A case report, J. Natl. Med. Assoc. 84, 368-370 (1992).
23. 23. Wronski, M., De Palma, P., and Arbit, E. Leiomyosarcoma of the uterus metastatic to brain: A case report and a review of the literature, Gynecol. Oncol. 54, 237-241 (1994).
24. 24. Montague, A. C. W., Swartz, D. P., and Woodruff, J. D. Sarcoma arising in a leiomyoma of the uterus: Factors influencing prognosis, Am. J. Obstet. Gynecol. 92, 421-427 (1965).
25. 25. Silverberg, S. G. Leiomyosarcoma of the uterus: A clinicopathological study, Obstet. Gynecol. 38, 613-619 (1971).
26. 26. Van Dinh, T., and Woodruff, J. D. Leiomyosarcoma of the uterus, Am. J. Obstet. Gynecol. 144, 817-823 (1982).
27. 27. Ben-Baruch, G., Amir, G., Menczer, J., and Bubis, J. M. Uterine sarcomas in Israeli patients: A clinicopathological study, Israel J. Med. Sci. 20, 211-215 (1984).
28. 28. George, M., Pejovic, M. H., Kramar, A., and Gynecologic Cooperating Group of French Oncology Centers. Uterine sarcomas: Prognostic factors and treatment modalities - Study on 209 patients, Gynecol. Oncol. 24, 58-67 (1986).
29. 29. Marchese, M. J., Liskow, A. S., Crum, C. P., McCaffrey, R. M., and Frick, H. C. Uterine sarcomas: A clinicopathologic study, 1965-1981, Gynecol. Oncol. 18, 299-312 (1984).
30. 30. Malmstrom, H., Schmidt, H., Persson, P. G., Carstensen, J., Nordenskjold, B., and Simonsen, E. Flow cytometric analysis of uterine sarcoma: Ploidy and S-phase rate as prognostic indicators, Gynecol. Oncol. 44, 172-177 (1992).
31. 31. Major, F. J., Blessing, J. A., Silverberg, S. G., Morrow, C. P., Creasman, W. T., Currie, J. L., Yordan, E., and Brady, M. F. Prognostic factors in early-stage uterine sarcoma: A Gynecologic Oncology Group study, Cancer 71(Suppl. 4), 1702-1709 (1993).
32. 32. Davids, A. Myomectomy, surgical technique and results in a series of 1150 cases, Am. J. Obstet. Gynecol. 63, 592-604 (1952).
33. 33. Madej, J., Bocian, J., and Basta, A. On the possibility of sparing surgical treatment of leiomyosarcoma in young women, Ginekol. Pol. 56, 9-12 (1985).
34. 34. DiSaia, P. J., Morrow, C. P., Boronow, R., Creasman, W., and Mittelstaedt, L. Endometrial sarcoma: Lymphatic spread pattern, Am. J. Obstet. Gynecol. 130, 104-105 (1978).
35. 35. Aaro, L. A., Symmonds, R. E., and Doherty, M. B. Sarcoma of the uterus: A clinical and pathologic study of 177 cases, Am. J. Obstet. Gynecol. 94, 101-109 (1966).
36. 36. Chen, S. S. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus, Gynecol. Oncol. 32, 215-217 (1989).
37. 37. Goff, B. A., Rice, L. W., Fleischhacker, D., Muntz, H. G., Falkenberry, S. S., Nikrui, N., and Fuller, A. F., Jr. Uterine leiomyosarcoma and endometrial stromal sarcoma: Lymph node metastases and sites of recurrence, Gynecol. Oncol. 50, 105-109 (1993).
38. 38. Belgrad, R., Elbadawi, N., and Rubin, P. Uterine sarcoma, Radiology 114, 181-188 (1975).
39. 39. Gilbert, H. A., Kagan, A. R., Lagasse, L., Jacobs, M. R., and Tawa, K. The value of radiation therapy in uterine sarcoma, Obstet. Gynecol. 45, 84-88 (1974).
40. 40. Rose, P. G., Boutsellis, J. G., and Sachs, L. Adjuvant therapy for stage I uterine sarcoma, Am. J. Obstet. Gynecol. 156, 660-662 (1987).
41. 41. Buchsbaum, H. J., Lifshitz, S., and Blythe, J. G. Prophylactic chemotherapy in stage I and II uterine sarcoma, Gynecol. Oncol. 8, 346-348 (1979).
42. 42. Hannigan, E. V., Freedman, R. S., and Rutledge, F. N. Adjuvant chemotherapy in early uterine sarcoma, Gynecol. Oncol. 15, 56-64 (1983).
43. 43. Omura, G. A., Blessing, J. A., Major, F., Lifshitz, S., Ehrlich, C. E., Mangan, C., Beecham, J., Park, R., and Silverberg, S. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group study, J. Clin. Oncol. 3, 1240-1245 (1985).
44. 44. Picci, P., Bacci, G., and Gherlinzoni, F. Results of a randomized trial for the treatment of localized soft tissue tumors (STS) of the extremities in adult patients, in Recent concepts in sarcoma treatment (B. L. Ryan, Jr., Ed.), Kluwer Academic, Dordrecht, Netherlands, pp. 144-148 (1988).
45. 45. Ravaud, A., Nguyen, B. B., and Coindre, J. M. Adjuvant chemotherapy with CyVADIC in high-risk soft tissue sarcoma: A randomized prospective trial, in Adjuvant therapy of cancer VI (S. E. Salmon, Ed.), Saunders, Philadelphia, PA, pp. 556-566 (1990).
46. 46. Chang, A. E., Kinsella, T., Glatstein, E., Baker, A. R., Sindelar, W. F., Lotze, M. T., Danforth, D. N., Jr., Sugarbaker, P. PH., Lack, E. E., and Steinberg, S. M. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity, J. Clin. Oncol. 6, 1491-1500 (1988).
47. 47. Alvegard, T. A., Sigurdsson, H., Mouridsen, H., Solheim, O., Unsgaard, B., Ringborg, U., Dahl, O., Nordentoft, A. M., Blomqvist, C., and Rydholm, A. Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group, J. Clin. Oncol. 1, 1504-1513 (1989).
48. 48. Mazanet, R., and Antman, K. H. Adjuvant therapy for sarcomas, Semin. Oncol. 18, 603-612 (1991).
49. 49. Elias, A., Ryan, L., Sulkes, A., Collins, J., Aisner, J., and Anthan, K. H. Response to doxorubicin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy, J. Clin. Oncol. 1, 1208-1216 (1989).
50. 50. Casali, P., Pastorino, U., Santoro, A., Zucchinelli, P., Azzarelli, A., and Bonadonna, G. Epirubicin, ifosfamide, and dacarbazine (EID) combined with surgery in advanced soft tissue sarcomas, Proc. Am. Soc. Clin. Oncol. 10, 353 (1991). [Abstract 1255]
51. 51. Omura, G. A., Major, F. J., Blessing, J. A., Sedlacek, T. V., Thigpen, J. J., Creasman, W. T., and Zaiho, R. J. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas, Cancer 52, 626-632 (1983).
52. 52. Hannigan, E. V., Freedman, R. S., Elder, K. W., and Rutledge, F. N. Treatment of advanced uterine sarcoma with vincristine, actinomycin D and cyclophosphamide, Gynecol. Oncol. 15, 224-229 (1983).
53. 53. Muss, H. B., Bundy, B., DiSaia, P. J., Homesley, H. D., Fowler, W. C. Jr., Creasman, W., and Yordan, E. Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncologic Group), Cancer 55, 1648-1653 (1985).
54. 54. Buxton, J., and Blackledge, G. Chemotherapy in gynaecological malignancies other than ovarian cancer and gestational trophoblastic tumours, in Clinical gynaecological oncology (J. H. Shepherd and J. M. Monaghan, Eds.), Blackwell Sci., Oxford/London, pp. 279-298 (1994).
55. 55. Levenback, C., Rubin, S. C., McCormack, P. M., Hoskins, W. J., Atkinson, E. N., and Lewis, J. L. Jr. Resection of pulmonary metastases from uterine sarcomas, Gynecol. Oncol. 45, 202-205 (1992).
56. 56. Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., MacDonald, J. S., and Young, B. A randomized trial of surgery in the treatment of single metastases to the brain, N. Engl. J. Med. 322, 494-500 (1990).